The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program. These are high-cost drugs covered ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...
On May 12, the Centers for Medicare & Medicaid Services (CMS) published the draft guidance for the Medicare Drug Price Negotiation Program’s (DPNP’s) third cycle (2028). The draft guidance, open for a ...
340B covered entities are expanding contracts with retail pharmacies that are increasingly located in counties with high rates of Medicare and Medicaid insurance coverage. The 340B Drug Pricing ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
February 26, 2026 - A newly released advisory by the U.S. Department of Health and Human Services' Office of Inspector General (HHS OIG) on how direct-to-consumer (DTC) prescription drug programs ...
Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known as the 340B drug pricing program — say they are closing in on legislation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results